OMIC: Singular Genomics Systems, Inc. Long-Term Debt Volume

Corporate emblem and logo of Singular Genomics Corp (OMIC)

Singular Genomics Systems (OMIC) generates revenue from the supply of sequencing systems, utilizing a recurring sales model for components to maintain high FCF. Business process efficiency is achieved by outsourcing electronics assembly and logistics to third-party contractors. The price action chart provided below reflects the trend amid growing demand from biotech laboratories. The current debt load is 0.05.

OMIC (Singular Genomics Systems, Inc.) Company Long-Term Debt history from 07/04/2022 to 03/01/2025

Singular Genomics Systems Inc (OMIC) - metric breakdowns and financial figures

- price and consensus price forecast:
Stock Price singulargenomics.com|OMIC - Price Target Chart
- market capitalization data:
Market Capitalization Singular Genomics|OMIC - Enterprise Value
- book capitalization data:
Net Assets per Share Singular Genomics|OMIC - Company Book Value|Capitalization to Book Value Ratio singulargenomics.com|OMIC - Company Total Assets
- debt and liquidity data:
Debt to Capital Ratio Singular Genomics Systems|OMIC - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Singular Genomics Corp|OMIC - Company Debts|Debt to Book Capitalization Ratio Singular Genomics|OMIC - Company Long-Term Debts|Company Short-Term Debts Singular Genomics
Analysis of all company metrics:OMIC (singulargenomics.com)
Mass-produced product of Singular Genomics Systems Inc

This indicator captures the total volume of credit obligations for Singular Genomics Systems (OMIC) with maturities exceeding twelve months. The metric assesses the long-term debt load and the stability of the company's liability structure. By analyzing changes in the issuer's long-term liabilities, investors can determine the default risk in the event of declining liquidity. An increase in borrowings may signal a search for resources to fund expansion. Amid geopolitical fragmentation of the sequencing market, such debts become critical when export flows are restricted.

Who Singular Genomics Systems competes with

Tempus Labs - Company Long-Term Debts|Company Long-Term Debt QGEN (Qiagen)|IONS - Long-Term Debt Volume|Repligen Corp. - Company Long-Term Debts|RNA (Avidity Corp) - Long-Term Debt Volume|Company Long-Term Debt CRISPR Therapeutics AG (CRSP)|Company Long-Term Indebtedness genedx.com|RARE: Company Long-Term Debts|Long-Term Indebtedness Beam Therapeutics Inc BEAM|Company Long-Term Liabilities SRPT (Sarepta Therapeutics Inc)|Twist Bioscience Corp - Company Long-Term Debts|TXG - Company Long-Term Debt|NTLA - Company Long-Term Debt|STOK: Company Long-Term Debts|BLFS (BioLife Solutions Inc) - Company Long-Term Debts|WVE - Company Long-Term Debt|Company Long-Term Loans and Borrowings Maze Therapeutics Corp (MAZE)|Sionna Therapeutics Inc (SION) - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings primemedicine.com (PRME)|TSHA (Taysha Gene Therapies, Inc.) - Company Long-Term Debts|Long-Term Indebtedness uniQure NV QURE|MGTX (MeiraGTx PLC) - Company Long-Term Debts|RGNX: Long-Term Debt|Company Long-Term Debt Solid Biosciences Inc.|OCGN (ocugen.com) - Company Long-Term Indebtedness|Company Long-Term Debt PACB (PacBio)|Long-Term Debt BNTC|Company Long-Term Debt DSGN (Design Pharma)|Company Long-Term Liabilities Rocket Corp (RCKT)|Company Long-Term Debts FDMT|Long-Term Debt Volume Lexeo Therapeutics Inc. LXEO|KRRO: Company Long-Term Debts|EDIT: Company Long-Term Liabilities|Silence Therapeutics Inc. - Company Long-Term Debt|Long-Term Debt Volume ProQR Therapeutics|CDXS - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings SGMO|NAUT (Nautilus Biotechnology) - Company Long-Term Debt|Long-Term Debt Volume Metagenomi Inc. MGX|DTIL: Company Long-Term Liabilities|Generation Bio Co - Long-Term Debt|Company Long-Term Debt BOLD (Boundless Bio, Inc.)|Exicure, Inc. (XCUR) - Long-Term Debt Volume|IMNN - Company Long-Term Liabilities|Phio Pharmaceuticals Corp. (PHIO) - Amount of Long-Term Liabilities|Company Long-Term Debts MBIO (Mustang Bio Inc)|Long-Term Debt RNAZ|Company Long-Term Debt BNGO (Bionano Genomics, Inc.)|Company Long-Term Liabilities APDN (adnas.com)|Company Long-Term Debt BLUE|ImmunoPrecise Antibodies Ltd - Long-Term Debt Volume|OMGA (Omega) - Company Long-Term Debt|RGLS: Long-Term Debt|SYRS (Syros Pharmaceuticals) - Company Long-Term Debt|telesisbio.com (TBIO) - Company Long-Term Liabilities|TCON: Company Long-Term Debts|Long-Term Debt Volume Unity Biotechnology Inc.